Video | 04 April 2022 Why we’re asking governments to reject the leaked text on COVID-19 at the WTO COVID-19 Leena Menghaney outlines why the leaked TRIPS Waiver doesn't go anywhere near far enough in terms of addressing the development of COVID-19 treatments, vaccines and diagnostics. Read, watch, share Filter by - Any -BlogEventsExplainerFeature storyInterviewIssue briefLetterNewsletterOpinion articlePress releaseSpeechSpotlightStatementTechnical briefVideo Events | 03 November 2021 COVID-19 Webinar: COVID-19 shows need to boost production of medical diagnostic tools in Asia Technical brief | 28 October 2021 COVID-19 Lessons learned and recommendations to ensure access to vaccines, medicines and diagnostics in the COVID-19 pandemic response and beyond Photo by Tracy Makhlouf/MSF Press release Press release | 27 October 2021 COVID-19 MSF responds to BioNTech’s announcement that it will establish production facilities in African countries 3 min Photo by Mariana Abdalla/MSF Press release Press release | 27 October 2021 COVID-19 License between Merck and Medicines Patent Pool for global production of promising new COVID-19 drug molnupiravir disappoints in its access limitations 4 min Photograph by Karabo Shai Press release Press release | 15 October 2021 COVID-19 MSF responds to another misleading attempt by EU to undermine TRIPS Waiver 4 min Photograph by Pierre-Yves Bernard Press release Press release | 14 October 2021 COVID-19 MSF warns of deadly TB testing gap following release of WHO Global TB Report 2021 4 min Photograph by Candice Sehoma Press release Press release | 12 October 2021 COVID-19 As time runs out to break ‘TRIPS Waiver’ stalemate, protesters at US and EU embassies in South Africa warn “The whole world is watching you.” 5 min Newsletter Newsletter | 12 October 2021 COVID-19 Break the TRIPS Waiver deadlock! Load More
Events | 03 November 2021 COVID-19 Webinar: COVID-19 shows need to boost production of medical diagnostic tools in Asia
Technical brief | 28 October 2021 COVID-19 Lessons learned and recommendations to ensure access to vaccines, medicines and diagnostics in the COVID-19 pandemic response and beyond
Photo by Tracy Makhlouf/MSF Press release Press release | 27 October 2021 COVID-19 MSF responds to BioNTech’s announcement that it will establish production facilities in African countries 3 min
Photo by Mariana Abdalla/MSF Press release Press release | 27 October 2021 COVID-19 License between Merck and Medicines Patent Pool for global production of promising new COVID-19 drug molnupiravir disappoints in its access limitations 4 min
Photograph by Karabo Shai Press release Press release | 15 October 2021 COVID-19 MSF responds to another misleading attempt by EU to undermine TRIPS Waiver 4 min
Photograph by Pierre-Yves Bernard Press release Press release | 14 October 2021 COVID-19 MSF warns of deadly TB testing gap following release of WHO Global TB Report 2021 4 min
Photograph by Candice Sehoma Press release Press release | 12 October 2021 COVID-19 As time runs out to break ‘TRIPS Waiver’ stalemate, protesters at US and EU embassies in South Africa warn “The whole world is watching you.” 5 min
